B

Brainstorm Cell Therapeutics
D

BCLI

2.26000
USD
0.23
(11.33%)
مغلق
حجم التداول
4,335
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
12,889,743
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    APLS
    0.090
    (0.27%)
    33.220 USD
    A
    ASND
    -1.560
    (-1.13%)
    136.110 USD
    A
    ATHA
    0.03110
    (5.76%)
    0.57130 USD
    M
    MBIO
    0.00590
    (3.49%)
    0.17490 USD
    M
    MDB
    0.820
    (0.33%)
    245.820 USD
    Q
    QURE
    1.550
    (10.00%)
    17.050 USD
    R
    RYTM
    0.550
    (0.99%)
    56.070 USD
    V
    VYGR
    0.06000
    (1.05%)
    5.76000 USD
    المزيد
الأخبار

العنوان: Brainstorm Cell Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.